Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease

被引：0
|
作者：
Fueller, D. [1 ]
Liu, C. [1 ]
Ko, Y. -A. [1 ]
Alkhoder, A. [1 ]
Desai, S. R. [1 ]
Almuwaqqat, Z. [1 ]
Patel, S. A. [1 ]
Ejaz, K. [1 ]
Kauser, T. [1 ]
Martini, A. [1 ]
Alvi, Z. [1 ]
Mehta, P. K. [1 ]
Sperling, L. S. [1 ]
Quyyumi, A. A. [1 ]
机构：
[1] Emory Clin Cardiovasc Res Inst, Atlanta, GA USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in exacerbated COPD
    Jorgensen, Ditte Vendelbo
    Godtfredsen, Nina Skalvan
    Marsaa, Kristoffer
    Ulrik, Charlotte Suppli
    Andersen, Ove
    Eugen-Olsen, Jesper
    Rasmussen, Line Jee Hartmann
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [32] Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    Joyce, Jessica
    Cabanas, Noel
    Pisharody, Rohan
    Ouyang, Bichun
    Patel, Roshni
    Reiser, Jochen
    Hall, Deborah A.
    Witek, Natalie
    PARKINSONISM & RELATED DISORDERS, 2022, 101 : 39 - 42
  • [33] Soluble urokinase Plasminogen Activator Receptor (suPAR) serum levels are elevated in patients with neuroendocrine neoplasia
    Burcin, Oe
    Mohr, R.
    Jann, H.
    Geisler, L.
    Tacke, F.
    Wiedenmann, B.
    Roderburg, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 96 - 96
  • [34] Soluble urokinase plasminogen activator receptor (suPAR) is associatedwith COPD readmission and mortality
    Hakansson, Kjell Erik Julius
    Ulrik, Charlotte Suppli
    Godtfredsen, Nina Skavlan
    Kallemose, Thomas
    Andersen, Ove
    Eugen-Olsen, Jesper
    Marsaa, Kristoffer
    Rasmussen, Line J. H.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [35] Soluble urokinase plasminogen activator receptor (SuPAR) in patients with plasma cell dyscrasias, a pilot study
    Sudhini, Yashwanth
    Dhakal, Binod
    Reiser, Jochen
    Altintas, Mehmet
    Hahm, Eunsil
    Peev, Vasil
    Venugopal, Parameswaran
    Paner, Agne
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S283 - S284
  • [36] SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS ASSOCIATED WITH KDIGO CHRONIC KIDNEY DISEASE STAGE IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE
    Yussef, Sarah Mohammed
    Ursli, Martin
    Rothschild, Inke
    Faraj-Allah, Ayah
    Koppensteiner, Renate
    Schernthaner, Gerit-Holger
    Hoebaus, Clemens
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 161 - 161
  • [37] Soluble urokinase plasminogen activator receptor and vulnerable plaque: high suPAR is associated with larger coronary plaque necrotic core and dense calcium in non-obstructive coronary artery disease
    Lee, S.
    Sandesara, P.
    Eshtehardi, P.
    Hayek, S.
    Tahhan, A. S.
    Hung, O. Y.
    Corban, M. T.
    Rabah, R.
    Gandhi, R.
    Hosseini, H.
    Chand, N.
    Gogas, B. D.
    Shaw, L. J.
    Quyyumi, A. A.
    Samady, H.
    EUROPEAN HEART JOURNAL, 2017, 38 : 393 - 393
  • [38] Soluble urokinase plasminogen activator receptor and functionally relevant coronary artery disease: a prospective cohort study
    Walter, Joan Elias
    Amrein, Melissa Lee Fen
    Schafer, Ibrahim
    Zimmermann, Tobias
    Lopez-Ayala, Pedro
    Boeddinghaus, Jasper
    Twerenbold, Raphael
    Puelacher, Christian
    Nestelberger, Thomas
    Wussler, Desiree
    Honegger, Ursina
    Badertscher, Patrick
    Eugen-Olsen, Jesper
    Koechlin, Luca
    Fahrni, Gregor
    Jeger, Raban
    Kaiser, Christoph
    Zellweger, Michael
    Mueller, Christian
    BIOMARKERS, 2022, 27 (03) : 278 - 285
  • [39] Soluble Urokinase Plasminogen Activator Receptor A Risk Factor for Carotid Plaque, Stroke, and Coronary Artery Disease
    Persson, Margaretha
    Ostling, Gerd
    Smith, Gustav
    Hamrefors, Viktor
    Melander, Olle
    Hedblad, Bo
    Engstrom, Gunnar
    STROKE, 2014, 45 (01) : 18 - 23
  • [40] Soluble urokinase plasminogen activator receptor and functionally relevant coronary artery disease: a prospective cohort study
    Walter, J. E.
    Amrein, M.
    Koechlin, L.
    De lavallaz, J. Du Fay
    Zimmermann, T.
    Twerenbold, R.
    Mueller, C.
    EUROPEAN HEART JOURNAL, 2019, 40 : 4036 - 4036
12345